NDC codes

409238 NDC codes with hospital pricing data in the network.

• NDC 409379501 — Ketorolac Tromethamine Inj 30 MG/ML (99 hospitals, 802–1,369 samples)
• NDC 70069010125 — METHOCARBAMOL 100 MG/ML INJECTION SOLUTION (153 hospitals, 1,144–1,369 samples)
• NDC 00641620701 — LORAZEPAM 2 MG/ML IJ SOLN (61 hospitals, 379–1,369 samples)
• NDC 00270-1411-11 — DEXAMETHASONE 0.75 MG TABLET (152 hospitals, 936–1,368 samples)
• NDC 70860030210 — FUROSEMIDE 10 MG ML INJECTION SOLN (47 hospitals, 441–1,368 samples)
• NDC 63323-0047-01 — HEPARIN (PORCINE) 5000 UNIT/ML INJECTION SOLUTION (18 hospitals, 1,079–1,367 samples)
• NDC 00185-0055-01 — METOLAZONE 5 MG PO TABS (89 hospitals, 1,258–1,366 samples)
• NDC 00406-0124-01 — HYDROcodone bitartrate-acetaminophen (68 hospitals, 1,258–1,366 samples)
• NDC 44567-0702-25 — CEFTRIAXONE 2 GRAM SOLUTION FOR INJECTION (80 hospitals, 1,024–1,366 samples)
• NDC 00074-3826-11 — DIVALPROEX ER 250 MG TABLETEXTENDED RELEASE 24 HR (35 hospitals, 1,258–1,366 samples)
• NDC 00121-0775-04 — GUAIFENESIN-CODEINE 100-10 MG/5ML PO SOLN (59 hospitals, 1,258–1,366 samples)
• NDC 00527-1050-01 — ACETAZOLAMIDE 250 MG TABLET (43 hospitals, 1,258–1,366 samples)
• NDC 00527-2962-37 — CHLORPROMAZINE HCL 25 MG PO TABS (45 hospitals, 1,258–1,366 samples)
• NDC 00143-1771-01 — ISOSORBIDE DINITRATE 10 MG PO TABS (63 hospitals, 1,258–1,366 samples)
• NDC 00182-0555-89 — hydrALAZINE 50 mg Tab (10 hospitals, 1,258–1,366 samples)
• NDC 409427702 — LIDOCAINE HCL 20 MG/ML (2 %) INJECTION SOLUTION (108 hospitals, 1,033–1,366 samples)
• NDC 00338-0322-01 — THROMBIN (RECOMBINANT) 5,000 UNIT TOPICAL SOLUTION (156 hospitals, 1,238–1,364 samples)
• NDC 60687-0580-01 — GABAPENTIN 100 MG PO CAPS (130 hospitals, 1,193–1,364 samples)
• NDC 487950101 — ALBUTEROL 0.083 3ML (129 hospitals, 950–1,364 samples)
• NDC 00338000404 — WATER FOR IRRIGATION, STERILE SOLUTION (196 hospitals, 653–1,364 samples)
• NDC 0409341401 — METOCLOPRAMIDE 5 MG/ML SOLN (34 hospitals, 320–1,364 samples)
• NDC 0409341418 — METOCLOPRAMIDE 5 MG/ML INJECTION SOLUTION (36 hospitals, 320–1,364 samples)
• NDC 0409525502 — METOCLOPRAMIDE 5 MG/ML INJECTION SOLUTION (SO) (20 hospitals, 320–1,364 samples)
• NDC 0703450201 — METOCLOPRAMIDE HCL 5 MG/ML IJ SOLN (43 hospitals, 320–1,364 samples)
• NDC 0703450204 — METOCLOPRAMIDE HCL 5 MG/ML IJ SOLN (45 hospitals, 320–1,364 samples)
• NDC 2315524031 — METOCLOPRAMIDE HCL 5 MG/ML IJ SOLN (38 hospitals, 320–1,364 samples)
• NDC 2315524041 — METOCLOPRAMIDE 5 MG/ML SOLN (35 hospitals, 320–1,364 samples)
• NDC 7604510120 — METOCLOPRAMIDE HCL 5 MG/ML IJ SOLN (27 hospitals, 320–1,364 samples)
• NDC 00409298703 — AMPICILLIN-SULBACTAM 3 GRAM INTRAVENOUS SOLUTION (92 hospitals, 266–1,364 samples)
• NDC 51754-5060-01 — BETAMETHASONE ACETATE AND SODIUM PHOS 6 MG/ML SUSPENSION FOR INJECTION (89 hospitals, 507–1,362 samples)
• NDC 63323056497 — enoxaparin 40 mg/0.4 mL Soln-Inj (229 hospitals, 749–1,361 samples)
• NDC 00002-4453-01 — OLANZAPINE 5 MG ORAL TBDL (20 hospitals, 1,235–1,361 samples)
• NDC 00006-0619-68 — hydrocortisone 10 mg Tab (18 hospitals, 1,235–1,361 samples)
• NDC 00185-4400-51 — tiZANidine 4 mg Tab (10 hospitals, 1,235–1,361 samples)
• NDC 00000-1893-11 — MORPHINE 100MG/100ML PB (1 hospital, 1,334–1,361 samples)
• NDC 68516521609 — ALBUMIN, HUMAN INJ 25% (130 hospitals, 830–1,361 samples)
• NDC 69374-0920-05 — SUCCINYLCHOLINE-SOD CL,ISO(PF) 100 MG/5 ML (20 MG/ML) IV SYRG (52 hospitals, 1,153–1,360 samples)
• NDC 63323041536 — neostigmine 10 mg/10 mL Soln-Inj (99 hospitals, 613–1,360 samples)
• NDC 67253090110 — ALPRAZolam 0.5 mg Tab (61 hospitals, 1,252–1,360 samples)
• NDC 00143-9316-01 — LEVOFLOXACIN 500 MG/100 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK (24 hospitals, 1,351–1,360 samples)
• NDC 00641627701 — NEOSTIGMINE METHYLSULFATE 10 MG/10ML IV SOLN (33 hospitals, 613–1,360 samples)
• NDC 72603025125 — FUROSEMIDE 10 MG/ML INJECTION SOLUTION (72 hospitals, 451–1,360 samples)
• NDC 00487980100 — IPRATROPIUM BROMIDE 0.02 % SOLUTION FOR INHALATION (72 hospitals, 604–1,360 samples)
• NDC 65302050105 — NEOSTIGMINE METHYLSULFATE 5 MG/5 ML (1 MG/ML) INTRAVENOUS SYRINGE (33 hospitals, 613–1,360 samples)
• NDC 00641627710 — NEOSTIGMINE METHYLSULFATE 1 MG/ML INTRAVENOUS SOLUTION (34 hospitals, 613–1,360 samples)
• NDC 00517113401 — NEOSTIGMINE METHYLSULFATE 1 MG/ML INTRAVENOUS SOLUTION (43 hospitals, 613–1,360 samples)
• NDC 65302050103 — NEOSTIGMINE METHYLSULFATE 3 MG/3 ML (1 MG/ML) INTRAVENOUS SYRINGE (23 hospitals, 613–1,360 samples)
• NDC 00517113405 — NEOSTIGMINE METHYLSULFATE 1 MG/ML INTRAVENOUS SOLUTION (28 hospitals, 613–1,360 samples)
• NDC 46287-0006-60 — SODIUM POLYSTYRENE SULFONATE 15 GM/60ML SUSP (COMBINED) (227 hospitals, 1,323–1,359 samples)
• NDC 12496120803 — BUPRENORPHINE 8 MG-NALOXONE 2 MG SUBLINGUAL FILM (179 hospitals, 261–1,359 samples)